Personalized breast cancer screening strategies: A systematic review and quality assessment

Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer

(2019) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Addition of ultrasound to mammography in the case of dense breast tissue: systematic review and meta-analysis

(2018) Matejka Rebolj et al.   BRITISH JOURNAL OF CANCER

Interval Breast Cancer Rates and Histopathologic Tumor Characteristics after False-Positive Findings at Mammography in a Population-based Screening Program

(2018) Solveig Hofvind et al.   RADIOLOGY

Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer

(2018) Nora Pashayan et al.   JAMA Oncology

Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology

(2018) Therese B. Bevers et al.   Journal of the National Comprehensive Cancer Network

Evaluation of a Stratified National Breast Screening Program in the United Kingdom: An Early Model-Based Cost-Effectiveness Analysis

(2017) Ewan Gray et al.   VALUE IN HEALTH

Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement

(2016) Albert L. Siu et al.   ANNALS OF INTERNAL MEDICINE

Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes

(2016) Amy Trentham-Dietz et al.   ANNALS OF INTERNAL MEDICINE

Breast Density and Benign Breast Disease: Risk Assessment to Identify Women at High Risk of Breast Cancer

(2015) Jeffrey A. Tice et al.   JOURNAL OF CLINICAL ONCOLOGY

MRI breast screening in high-risk women: cancer detection and survival analysis

(2014) Evans D. Gareth et al.   BREAST CANCER RESEARCH AND TREATMENT

Cost-effectiveness of alternative strategies for integrating MRI into breast cancer screening for women at high risk

(2014) C H Ahern et al.   BRITISH JOURNAL OF CANCER

The Influence of Disease Risk on the Optimal Time Interval between Screens for the Early Detection of Cancer

(2014) James F. O’Mahony et al.   MEDICAL DECISION MAKING

Cost-Effectiveness and Harm-Benefit Analyses of Risk-Based Screening Strategies for Breast Cancer

(2014) Ester Vilaprinyo et al.   PLoS One

Questionnaire to Assess Relevance and Credibility of Modeling Studies for Informing Health Care Decision Making: An ISPOR-AMCP-NPC Good Practice Task Force Report

(2014) J. Jaime Caro et al.   VALUE IN HEALTH

Personalizing Mammography by Breast Density and Other Risk Factors for Breast Cancer: Analysis of Health Benefits and Cost-Effectiveness

(2013) John T. Schousboe et al.   ANNALS OF INTERNAL MEDICINE

Individually tailored screening of breast cancer with genes, tumour phenotypes, clinical attributes and conventional risk factors

(2013) Y-Y Wu et al.   BRITISH JOURNAL OF CANCER

The benefits and harms of breast cancer screening: an independent review

(2013) M G Marmot et al.   BRITISH JOURNAL OF CANCER

Tailored Breast Cancer Screening Program with Microdose Mammography, US, and MR Imaging: Short-term Results of a Pilot Study in 40–49-Year-Old Women

(2013) Elena Venturini et al.   RADIOLOGY

Detection of Breast Cancer With Addition of Annual Screening Ultrasound or a Single Screening MRI to Mammography in Women With Elevated Breast Cancer Risk

(2012) Zheng Zhang   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

False-Positive Results in Mammographic Screening for Breast Cancer in Europe: A Literature Review and Survey of Service Screening Programmes

(2012) Solveig Hofvind et al.   JOURNAL OF MEDICAL SCREENING

Unlocking the value of personalised healthcare in Europe—breast cancer stratification

(2012) Walter Van Dyck et al.   Health Policy and Technology

Effect of protocol-related variables and women's characteristics on the cumulative false-positive risk in breast cancer screening

(2011) R. Roman et al.   ANNALS OF ONCOLOGY

Polygenic susceptibility to prostate and breast cancer: implications for personalised screening

(2011) N Pashayan et al.   BRITISH JOURNAL OF CANCER

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE